Sergio Santillana

Insider Reports History

Entity
Individual
Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Sergio Santillana
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sergio Santillana:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ikena Oncology, Inc. Chief Medical Officer Stock Option (Right to Buy) 105K Jan 3, 2023 Direct

Insider Reports Filed by Sergio Santillana

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKNA Ikena Oncology, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Medical Officer
IKNA Ikena Oncology, Inc. Feb 2, 2022 1 $0 4 Feb 4, 2022 Chief Medical Officer